BioNTech CEO Ugur Sahin sells ordinary shares worth $7.86 million
BNTX•CEO shares sale disclosed under trading plan
BioNTech CEO Ugur Sahin sold 76,500 ordinary shares on Sept. 3-4, 2026, trimming his stake to 781,709 shares.
The sales were priced at USD 102.85 to USD 103.52 per share.
The transactions were executed under a Rule 10b5-1 trading plan adopted on June 3, 2026.




